19th January 2015

Cell Therapy Catapult and TrakCel to Collaborate on Research Project

Cell Therapy Catapult and TrakCel to Collaborate on Research Project

Cell Therapy Process Management solution to be analysed in a GMP-compliant environment

CARDIFF, WALES, UK January 19 2015 – The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, and TrakCel, a provider of supply chain integration management technology for cell therapies, today announced a research collaboration agreement to explore the utility of TrakCel’s technology in mission-critical situations.

To test Trakcel’s solution in a GMP-compliant environment, over the next three years each company will provide resources, facilities and personnel to form a project team. Beginning in early 2015, the Cell Therapy Catapult will provide advisory feedback and product enhancement input throughout the duration of the project for the benefit of TrakCel’s solution development in cell therapy planning, manufacturing, regulatory and clinical affairs.

TrakCel technology improves cell therapy process success by proactively instructing professionals within the supply chain whilst providing real-time visibility to stakeholders.  As well as reducing the implementation risks associated with disparate, paper-based systems, the information collected by TrakCel technology enables greater insight into clinical trial data and provides a foundation for regulatory audits.

Keith Thompson, CEO of the Cell Therapy Catapult said:  “TrakCel is striving to improve the success of cell therapy processes by introducing an innovative approach to cell tracking and control technology that overcomes limitations of the existing industry methodology. Through providing access to our experts and facilities, we’re looking forward to jointly exploring its potential.”

TrakCel will install a system at the Cell Therapy Catapult for the purpose of stress testing and analysis in a series of mission-critical situations including inbound/outbound logistics. The project will command a full cell process mapping exercise as well as training for Catapult analysts and experts.

“The Cell Therapy Catapult is committed to fostering innovation and growth in the cell therapy industry.” said Kevin Smith, Director, TrakCel. “We’re excited to undertake this collaborative research project that will provide vital input to our development team and ultimately accelerate the advancement of our technology.”

The Cell Therapy Catapult will publish its initial findings as to the applicability of the TrakCel solution in the autumn of 2015.

TrakCel is exhibiting its cell therapy supply chain management technology at the Phacilitate Cell & Gene Therapy Forum, January 26-28, Washington, D.C..